Treating patients under strictly regulated conditions, i.e. within clinical trials, is essential for gaining new knowledge and optimizing existing therapies in the field of hematology and medical oncology. Clinical trials contribute to the quality assurance in the treatment of malignant diseases. We are the lead institution in several multicenter clinical trials and participate as a member of the protocol commission or as a study cite in many others.
Click here for a list of the current clinical trials available for patients in the Department of Hematology and Medical Oncology.